NHMRC Centre for Blood Transplant and Cell Therapies Webinar 17 October 2022
The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. This webinar features Professor Catherine Bollard, who is the current Program Director for Cell Enhancement and Technologies for Immunotherapies at the Children’s National Hospital, Associate Centre Director for Translational Research and Innovation at the GW Cancer Centre and Professor of Pediatrics and Microbiology, Immunology and Tropical Medicine at the George Washington University. Her bench and translational research has focused on improving post-transplant outcomes through developing novel cellular therapeutics, leading to over 200 peer reviewed publications and ongoing independent NIH funding for over a decade. In this webinar, Professor Bollard will be outlining the role of T cell therapies for lymphoma.
Professor Catherine Bollard – Children’s National Hospital, George Washington University
When: Friday 17 October 2022, 8am AEDT
Link to webinar:
Link to CBTCT website for all webinar recordings:
For more information click here
© 2023 Haematology Society of Australia & New Zealand All Rights Reserved.